NovMetaPharma Co., Ltd. (XKON:229500)
South Korea · Delayed Price · Currency is KRW 7,200.00
+400.00 (5.88%)
At close: Jul 20, 2026
NovMetaPharma Market Cap
NovMetaPharma has a market cap or net worth of 78.59 billion as of July 21, 2026. Its market cap has decreased by -43.64% in one year.
Market Cap
78.59B
Enterprise Value
n/a
Revenue
1.30B
Ranking
n/a
PE Ratio
51.00
Stock Price
7,200.00
ChartMarket Cap Chart
Since April 5, 2017, NovMetaPharma's market cap has increased from 74.59B to 78.59B, an increase of 5.36%. That is a compound annual growth rate of 0.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 78.59B | -51.99% |
| Dec 30, 2025 | 163.69B | 187.16% |
| Dec 30, 2024 | 57.00B | -46.33% |
| Dec 29, 2022 | 106.21B | -45.89% |
| Dec 30, 2021 | 196.29B | -9.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TiumBio | 118.05B |
| ViGenCell | 112.95B |
| Cell Biotech | 105.40B |
| Choong Ang Vaccine Laboratory | 87.40B |
| CORESTEMCHEMON | 83.18B |
| SunBio,Inc. | 75.11B |
| BIO-FD&C | 72.78B |
| CTCBIO | 70.05B |